Announcement of preclinical animal study results of OBI’s COVID-19 vaccine

1.Date of occurrence of the event: 2022/02/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): Head office 4.Reciprocal shareholding ratios: Not applicable 5.Cause of occurrence: Please refer to the press release on our website for preclinical animal study results of OBI’s COVID-19 vaccine. https://www.obipharma.com/ 6.Countermeasures: None 7.Any other […]